Titre:
  • Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists
Auteur:De Vos, Martine; Van Gossum, Marc; Macken, Elisabeth; Ferrante, Marc; Hindryckx, Pieter P.M.; Dewit, Olivier; Holvoet, Tom; Franchimont, Denis; Dhooghe, Barbara; Vermeire, Séverine; Louis, Edouard; Mana, Fazia; Elewaut, Ann; Bossuyt, Peter; Baert, Filip; Reenaers, Catherine
Informations sur la publication:United European gastroenterology journal, 6, 3, page (439-445)
Statut de publication:Publié, 2018-04
Sujet CREF:Généralités
Mots-clés:inflammatory bowel disease
observational study
refractory patients
Vedolizumab
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2050-6406
info:doi/10.1177/2050640617722310
info:scp/85044403863